thalidomide has been researched along with Carcinoma, Ehrlich Tumor in 10 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Carcinoma, Ehrlich Tumor: A transplantable, poorly differentiated malignant tumor which appeared originally as a spontaneous breast carcinoma in a mouse. It grows in both solid and ascitic forms.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This dosage form permits the prolonged drug release." | 1.39 | Evaluation of the effects of thalidomide-loaded biodegradable devices in solid Ehrlich tumor. ( Dantas Cassali, G; Ligorio Fialho, S; Maria de Souza, C; Pereira, BG; Silva-Cunha, A, 2013) |
| "Thalidomide has been reported to have anti-angiogenic and antimetastatic effects." | 1.36 | Effect of thalidomide dithiocarbamate analogs on the intercellular adhesion molecule-1 expression. ( Abdou, BY; Agwa, HS; Guirgis, AA; Mohamed, AS; Talaat, RM; Zahran, MA, 2010) |
| "Clotrimazole was the most potent antiangiogenic compound and the agent capable of inhibiting tumor growth." | 1.32 | Differential effects of antiangiogenic compounds in neovascularization, leukocyte recruitment, VEGF production, and tumor growth in mice. ( Andrade, SP; Barcelos, LS; Belo, AV; Ferreira, MA; Teixeira, MM, 2004) |
| "Thalidomide did not inhibit dehydrogenase activity or growth of Ehrlich ascites tumor cells in agar." | 1.24 | THALIDOMIDE: EFFECTS ON EHRLICH ASCITES TUMOR CELLS IN VITRO. ( DIPAOLO, JA; WENNER, CE, 1964) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zahran, MA | 2 |
| Salem, TA | 1 |
| Samaka, RM | 1 |
| Agwa, HS | 2 |
| Awad, AR | 1 |
| Guirgis, AA | 1 |
| Mohamed, AS | 1 |
| Talaat, RM | 1 |
| Abdou, BY | 1 |
| Pereira, BG | 1 |
| Ligorio Fialho, S | 1 |
| Maria de Souza, C | 1 |
| Dantas Cassali, G | 1 |
| Silva-Cunha, A | 1 |
| JURET, P | 1 |
| AUBERT, C | 1 |
| DIPAOLO, JA | 2 |
| PAGNINI, G | 1 |
| DICARLO, R | 1 |
| WENNER, CE | 1 |
| Belo, AV | 2 |
| Barcelos, LS | 1 |
| Teixeira, MM | 1 |
| Ferreira, MA | 2 |
| Andrade, SP | 2 |
| Bosco, AA | 1 |
| Machado, RD | 1 |
| De, AU | 1 |
| Pal, D | 1 |
10 other studies available for thalidomide and Carcinoma, Ehrlich Tumor
| Article | Year |
|---|---|
Design, synthesis and antitumor evaluation of novel thalidomide dithiocarbamate and dithioate analogs against Ehrlich ascites carcinoma-induced solid tumor in Swiss albino mice.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Antioxidants; Carcinoma, Ehrlich Tumor; Cat | 2008 |
Effect of thalidomide dithiocarbamate analogs on the intercellular adhesion molecule-1 expression.
Topics: Animals; Antineoplastic Agents; Carcinoma; Carcinoma, Ehrlich Tumor; Cell Adhesion; Female; Intercel | 2010 |
Evaluation of the effects of thalidomide-loaded biodegradable devices in solid Ehrlich tumor.
Topics: Absorbable Implants; Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Antineoplastic | 2013 |
[Absence of carcinostatic effect of thalidomide with respect to 2 grafted tumors].
Topics: Animals; Carcinoma; Carcinoma, Ehrlich Tumor; Neoplasms, Experimental; Thalidomide | 1963 |
IN VITRO TEST SYSTEMS FOR CANCER CHEMOTHERAPY. II. CORRELATION OF IN VITRO INHIBITION OF DEHYDROGENASE AND GROWTH WITH IN VIVO INHIBITION OF EHRLICH ASCITES TUMOR.
Topics: Animals; Antineoplastic Agents; Arsenicals; Carbamates; Carcinoma; Carcinoma, Ehrlich Tumor; Colchic | 1963 |
[TREATMENT OF EXPERIMENTAL TUMORS WITH THALIDOMIDE].
Topics: Animals; Carcinoma; Carcinoma, Ehrlich Tumor; Mice; Multiple Myeloma; Neoplasms; Neoplasms, Experime | 1963 |
THALIDOMIDE: EFFECTS ON EHRLICH ASCITES TUMOR CELLS IN VITRO.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Division; Folic Acid; In Vitro Techniques; Metabolism; Niaci | 1964 |
Differential effects of antiangiogenic compounds in neovascularization, leukocyte recruitment, VEGF production, and tumor growth in mice.
Topics: Acetylglucosaminidase; Angiogenesis Inhibitors; Animals; Anti-Inflammatory Agents; Carcinoma, Ehrlic | 2004 |
Differential effects of thalidomide on angiogenesis and tumor growth in mice.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Ehrlich Tumor; Granuloma, Foreign-Body; Male; Mice; Neo | 2001 |
Possible antineoplastic agents I.
Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Mice; Nitro Compounds; Phthalimides; Pyrid | 1975 |